Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer

by Lu, Janice
Published 2015

Targeted therapy for HER2 positive breast cancer

by Incorvati, Jason A, Shah, Shilpan, Mu, Ying, Lu, Janice
Published 2013

Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter ret...

by Wang, Yunchao, Sun, Tao, Wan, Donggui, Sheng, Lijun, Li, Wei, Zhu, Huayun, Li, Yanping, Lu, Janice
Published 2015